Lv7
4780 积分 2022-08-11 加入
Trends in the drug target landscape for autoimmune diseases
29天前
已完结
Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia
1个月前
已关闭
Are all the IL-23 blockers the same in inflammatory bowel disease?
2个月前
已完结
Povetacicept, an Enhanced Dual APRIL/BAFF Antagonist That Modulates B Lymphocytes and Pathogenic Autoantibodies for the Treatment of Lupus and Other B Cell–Related Autoimmune Diseases
2个月前
已完结
Best practice considerations for nonclinical in vivo cardiovascular telemetry studies in non-rodent species: Delivering high quality QTc data to support ICH E14/S7B Q&As
4个月前
已完结
Discovery of Novel Fourth-Generation EGFR Inhibitors to Overcome C797S-Mediated Resistance
4个月前
已完结
Practical Considerations in Determining Adversity and the No-Observed-Adverse-Effect-Level (NOAEL) in Nonclinical Safety Studies: Challenges, Perspectives and Case Studies
5个月前
已完结
Sotorasib for Vascular Malformations Associated with KRAS G12C Mutation
5个月前
已完结
Topical JAK inhibition ameliorates EGFR inhibitor–induced rash in rodents and humans
6个月前
已完结
Mechanisms of response and tolerance to active RAS inhibition in KRAS-mutant NSCLC
9个月前
已完结
皖公网安备34019202002308
